Outbreaks have surged in the South and West in the United States. As COVID-19 test positivity rates resurged in recent weeks, private test providers have made efforts to sound the alarm that the ...

Quest Diagnostics, the world’s leading provider of diagnostic information services, on Monday said demand for COVID-19 tests “continues to outpace” capacity. Demand for molecular testing is highest in ...

The private testing lab is ramping up tests at the behest of the government. In the two weeks since Quest Diagnostics began processing novel coronavirus samples in its infectious disease lab, the ...

Though countless diagnostic developers struck it rich at the height of the COVID-19 pandemic, many of those that were relatively new to the testmaking game are now struggling to make up for lost sales ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting ...

Our indicative theme of Covid-19 Testing Stocks– which includes the stocks of companies that produce or carry out tests for the highly infectious virus – is up by about 51% year-to-date, on an equally ...

Two of the nation’s largest clinical testing providers are launching their own assays for the novel coronavirus—moving forward this week after the FDA gave high-tech labs the green light to operate ...

Our indicative theme of Covid-19 Testing Stocks, which includes medical device and diagnostic companies that are involved in Covid-19 testing – is up by about 66% year-to-date, significantly ...